NCT07785895Not yet recruiting
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
Background: Hypertension (high blood pressure) is a major risk factor for heart disease and stroke, yet many people do not know they have it. In Malaysia, nearly half of all adults with elevated blood pressure are unaware of their condition. Standard clinic blood pressure checks can miss cases of high blood pressure or falsely flag temporary stress-related spikes. While 24-hour Ambulatory Blood Pressure Monitoring (ABPM) is the standard method for an accurate diagnosis, it is not practical for large-scale screening. Purpose: The purpose of this study is to evaluate whether a novel Huawei smartwatch, which uses photoplethysmography (PPG) technology to estimate blood pressure, can accurately identify individuals at high risk for hypertension in a real-world setting. Study Design \& Procedures: Participants: Approximately 500 adults will be enrolled over a 24-month study period. Screening: All participants will use the Huawei smartwatch screening tool to monitor their blood pressure estimates. Validation: A subgroup of approximately 50 participants identified as high-risk by the smartwatch will undergo 24-hour ABPM (the clinical gold standard) to confirm whether they have high blood pressure. Goal: Researchers aim to validate the accuracy of the smartwatch screening tool against 24-hour ABPM to determine if wearable technology can support early detection and timely treatment of undiagnosed hypertension in the community.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 18 Aug 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 30 Sept 2028
- Lead sponsor
- Sunway University
- Diseases
- High blood pressure
- NCT number
- NCT07785895
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Oct 2026 to the primary completion date, 30 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently on antihypertensive medications
Other illness
- Implantable cardiac devices (e.g., permanent pacemakers, implantable cardioverter-defibrillators \[ICDs\])
- Uncontrolled arrhythmias (e.g., active atrial fibrillation, frequent premature ventricular contractions \[PVCs\])
- Movement disorders or active tremors that interfere with signal acquisition (e.g., severe Parkinson's disease, essential tremor)
- Acute medical conditions, including:
- Acute coronary syndromes (e.g., recent myocardial infarction or unstable angina within the past 3 months)
- Acute cerebrovascular events (e.g., stroke or transient ischemic attack \[TIA\] within the past 3 months)
- Acute decompensated heart failure or severe respiratory distress
- Active, severe acute infections or systemic inflammatory illness (e.g., sepsis, acute pneumonia)
Other
- Current pregnancy
- Hypertensive emergencies or urgency
- Resting BP ≥180/110 mmHg.
Who the study is looking for
- Possesses the specific Huawei wearable required for the study
- Aged ≥18 years
- Malaysian citizen/permanent resident
- Understands English, Malay, or Chinese
- Able to download the required application on a compatible smartphone
- Willing to wear devices continuously
- Able to provide informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medical and Life Sciences, Sunway University Coordinator of this site? Confirm its status | Subang Jaya | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.